PERIPHERAL NERVE SOCIETY

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1983

Legal Domicile

Principal Officer

MICHAEL POLYDEFKIS MD M

Phone

9525456284

Tax Period

2023-01-01 to 2023-12-31

PERIPHERAL NERVE SOCIETY, founded in 1983, is a community nonprofit in the Diseases & Disorders sector that reported $1.8M in total revenue in fiscal year 2023. Revenue surged 30% from the prior year, signaling strong growth momentum. Expenses of $1.5M left a modest 12% surplus.

Mission

TO IMPROVE THE LIVES OF PEOPLE WITH PERIPHERAL NEUROPATHIES.

Program Service Accomplishments

Program 1

Expenses: $1,375,280 Revenue: $1,471,182

THE PERIPHERAL NERVE SOCIETY PROVIDES MEETINGS, TEACHING COURSES, GUIDELINES, AND OTHER RESOURCES TO AID IN THE EDUCATION OF MEMBERS. THE SOCIETY SPONSORS SCIENTIFIC MEETINGS WHERE SCIENTISTS DISCUSS ADVANCES IN UNDERSTANDING THE BASIC BIOLOGY AND FUNCTION OF THE PERIPHERAL NERVOUS SYSTEM, THE NATURE OF NERVE INJURY AND REPAIR, AND HOW THIS KNOWLEDGE MIGHT BE APPLIED TO CARE FOR PATIENTS WITH GENETIC, TRAUMATIC, TOXIC, OR METABOLIC NERVE DISEASE.MEMBERSHIP IN THE PERIPHERAL NERVE SOCIETY IS OPEN TO ANY PROFESSIONAL WITH INTEREST IN DISORDERS OF THE PERIPHERAL NERVOUS SYSTEM. MEMBERS OF THE PERIPHERAL NERVE SOCIETY MAY JOIN SEVERAL SPECIAL INTEREST GROUPS, INCLUDING THE INFLAMMATORY NEUROPATHY CONSORTIUM, CHARCOT-MARIE-TOOTH AND RELATED NEUROPATHIES CONSORTIUM, INTERNATIONAL DIABETES NEUROPATHY CONSORTIUM, TOXIC NEUROPATHY CONSORTIUM, AND NEUROPATHIC PAIN CONSORTIUM BY REQUEST.

Program 2

Expenses: $25,591 Revenue: $10,000

THE SOCIETY PUBLISHES THE JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WHICH IS A PEER REVIEWED SCIENTIFIC PUBLICATION WHOSE MAJOR GOAL IS TO DISSEMINATE NEW KNOWLEDGE ON ALL SCIENTIFIC AND CLINICAL...

THE SOCIETY PUBLISHES THE JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WHICH IS A PEER REVIEWED SCIENTIFIC PUBLICATION WHOSE MAJOR GOAL IS TO DISSEMINATE NEW KNOWLEDGE ON ALL SCIENTIFIC AND CLINICAL INFORMATION REGARDING THE PERIPHERAL NERVOUS SYSTEM.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $43,845

Program Service Revenue $1,481,182

Investment Income $180,845

Other Revenue $54,915

TOTAL REVENUE $1,760,787

Expense Breakdown

Grants Paid $130,295

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,400,871

Other Expenses $1,410,856

TOTAL EXPENSES $1,541,151

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,760,787	$1,356,001	+0.3%
Expenses	$1,541,151	$1,131,388	+0.4%
Net Income	$219,636	$224,613	0.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

200

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CHARLOTTE SUMNER MD	PRESIDENT	0.50	Officer Director	$0	$0	$0
ALESSANDRA BOLINO PHD	PRESIDENT-ELECT	0.50	Officer Director	$0	$0	$0
MICHAEL POLYDEFKIS MD MHS	SECRETARY/TREASURER	0.50	Officer Director	$0	$0	$0
RICHARD LEWIS MD	IMMEDIATE PAST PRESIDENT	0.50	Officer Director	$0	$0	$0
DAVID CORNBLATH MD	DIRECTOR	0.50	Director	$0	$0	$0
DANIELA MARIA MENICHELLA MD PHD	DIRECTOR	0.50	Director	$0	$0	$0
LUIS QUEROL MD PHD	DIRECTOR	0.50	Director	$0	$0	$0
STEFANO PREVITALI MD PHD	DIRECTOR	0.50	Director	$0	$0	$0
PETER VAN DEN BERGH MD PHD FEAN	DIRECTOR	0.50	Director	$0	$0	$0
CLAUDIA SOMMER MD	DIRECTOR	0.50	Director	$0	$0	$0
ALLISON KINDSETH	EXECUTIVE DIRECTOR	37.50	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,760,787	$1,541,151	$7,136,679	$219,636
2022	$1,356,001	$1,131,388	$6,134,599	$224,613
2021	$1,135,903	$508,116	$6,858,410	$627,787
2020	$668,318	$416,515	$5,822,481	$251,803
2019	$1,805,477	$948,016	$5,094,055	$857,461
2018	$1,233,886	$766,985	$3,510,014	$466,901